Background Image
Previous Page  38 / 39 Next Page
Information
Show Menu
Previous Page 38 / 39 Next Page
Page Background

38

43.

Reid IR, Nicholson GC, Weinstein RS, Hosking

DJ, Cundy T, Kotowicz MA, et al. Biochemical

and radiologic improvement in Paget's disease

of bone treated with alendronate: a randomized,

placebo-controlled

trial.

Am

J

Med.

1996;101:341-8.

44.

Miller PD, Brown JP, Siris ES, Hoseyni MS,

Axelrod DW, Bekker PJ. A randomized, double-

blind comparison of risedronate and etidronate

in the treatment of Paget's disease of bone.

Paget's Risedronate/Etidronate Study Group.

Am J Med 1999;106:513-20.

45.

Miller PD, Brown JP, Siris ES. A randomized,

double-blind comparison of risedronate and

etidronate in the treatment of Paget's disease of

bone. Paget's Risedronate/Etidronate Study

Group. Am J Med. 1999;106:513.

46.

Merlotti D, Gennari L, Martini G. Comparison

of different intravenous bisphosphonate

regimens for Paget's disease of bone. J Bone

Miner Res 2007;22:1510.

47.

Walsh JP, Ward LC, Stewart GO, Will RK,

Criddle RA. A randomized clinical trial

comparing oral alendronate and intravenous

pamidronate for the treatment of Paget's disease

of bone. Bone 2004;34:747.

48.

Reid IR, Miller P, Lyles K. Comparison of a

single infusion of zoledronic acid with